![]() MolMed MolMed is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies. | ![]() Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | ![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ![]() BioAtla BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer. | ![]() Dragonfly Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer. | |
Founding Date | Founding Date 1996 | Founding Date 2013 | Founding Date 2015 | Founding Date 2007 | Founding Date 2015 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Milano, IT HQ Bresso, IT | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US | Locations South San Francisco, US HQ | Locations San Diego, US HQ | Locations Waltham, US HQ |
Employees | Employees 186 | Employees 1241% increase | Employees 64 | Employees 616% decrease | Employees 109 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 100.8 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income (€427k) (FY, 2019) | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income ($59.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 451.9m | Total funding raised $ 176m | Total funding raised $ 186.5m | Total funding raised N/A |

Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.
View company
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
BioAtla is a biopharmaceutical company that develops antibody-based therapeutics for the treatment of solid tumor cancer.
View company
Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.
View company